D-1579-2019 Class II Terminated
FDA drug recall D-1579-2019 was initiated by ImprimisRx NJ on Jul 17, 2019 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Apr 22, 2020). Affected quantity: 246 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 7, 2019
- Initiation Date
- Jul 17, 2019
- Termination Date
- Apr 22, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 246 bottles
Product description
Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States
Code information
Lot #: 03132019@2, Exp. 09/17/2019; 05102019@2, Exp. 11/02/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1579-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026